UCB's Global Corporate Website
Welcome to UCB in the United States
  • Healthcare Professionals
  • Patients
  • Investors
  • Feb

    03

    Rare Disease Day 2025: Elevating the Lives of the Under-served and Under-represented

    Feb

    22

    Rare Disease Day 2024: The Moment is Now to Be Patient-First to Deliver for People Living with Rare Diseases

    Nov

    01

    UCB presents latest data from generalized myasthenia gravis portfolio at 2023 American Association of Neuromuscular & Electrodiagnostic Medicine (AANEM) Annual Meeting and Myasthenia Gravis Foundation of America (MGFA) Scientific Session

    Sep

    12

    Disease Spotlight: Thymidine Kinase 2 Deficiency (TK2d)

    Jun

    01

    Myasthenia Gravis Awareness Month is the Time to Understand More About the Lived Experiences of the Community

    Mar

    31

    Employee Spotlight: Judith Thompson’s Journey to Making a Larger Impact through Addressing Health Disparities for People Living with Severe Diseases

    Feb

    17

    Patient-First, Patient-Focused: Our Purpose and Promise

    Jan

    13

    Patient-first: UCB is there to listen to patients, to not only learn more about them but also from them

    Jun

    01

    Life with MG & What I Wish For Everyone Who is Diagnosed

    Feb

    25

    Recognizing Rare Disease Day Every Day – The Importance of Addressing Unmet Patient Needs

    At UCB, we work 365-days-a-year to find new ways to deliver solutions, peace of mind, and opportunities to people living with severe diseases because everyone deserves to live the best life they can.